Biopharmaceuticals Manufacturing Consumables Testing Industry

The global biopharmaceuticals manufacturing consumables testing market size is estimated to reach USD 1.27 billion by 2030, registering a CAGR of 12.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing need for an in-depth assessment of raw materials for the successful and rapid launch of the final product. Rising awareness pertaining to internal standards as well as external regulations in the biopharmaceutical industry is also aiding the market growth.

In the past few years, there has been a major paradigm shift from small chemical molecules to large biological molecules. As a result, the biopharmaceutical industry is geared toward exploring every aspect involved in the manufacturing process.

Regulatory and quality expectations for best quality raw materials and intermediates continue to increase. This, in turn, has pressurized vendors engaged in the manufacturing of excipients and raw materials to invest in standardizing functionality as well as establishing sophisticated processes to consistently address the needs of final product developers.

Curious about the Biopharmaceuticals Manufacturing Consumables Testing Market, Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Biopharmaceuticals Manufacturing Consumables Testing Market Segments Highlights:

• Based on service, compendial and multi-compendial testing held the largest share, owing to demand from various manufacturers for raw materials that are compliant to regulatory standards.
• Based on raw material, the active pharmaceutical ingredients (APIs) segment accounted for the largest revenue share, owing to the presence of a wide range of services in this segment.
• Presence of a large number of biologics manufacturing entities in the U.S. has resulted in North America dominating the global market in 2024. Rising competitive rivalry amongst market participants is also attributive for the large share of this region.
• Asia Pacific is expected to grow at a significant CAGR over the forecast period, fueled primarily by expansion of the contract service industry in several Asian countries. This is partly attributed to low operating costs in these nations.

Biopharmaceuticals Manufacturing Consumables Testing Market Report Segmentation

Grand View Research has segmented the global biopharmaceuticals manufacturing consumables testing market based on service, raw material, and region:

Biopharmaceuticals Manufacturing Consumables Testing Service Outlook (Revenue, USD Million, 2018 - 2030)

• Laboratory Testing
• Custom Testing / Customer Proprietary Testing
• Compendial Multi Compendial Laboratory Testing

Biopharmaceuticals Manufacturing Consumables Testing Raw Material Outlook (Revenue, USD Million, 2018 - 2030)

• Formulation Excipients
• Active Pharmaceutical Ingredients (API)
• Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support

Biopharmaceuticals Manufacturing Consumables Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Biopharmaceuticals Manufacturing Consumables Testing Company Insights

• Alcami Corporation
• Merck KGaA
• Eurofins Scientific
• Agilent Technologies, Inc.
• Charles River Laboratories.
• Catalent, Inc
• Element Materials Technology (Avomeen Analytical Services)
• Pace Analytical Services, LLC
• Nelson Laboratories, LLC (Gibraltar Laboratories)

Order a free sample PDF of the Biopharmaceuticals Manufacturing Consumables Testing Market Intelligence Study, published by Grand View Research.